Honasa acquires 58% stake in Fluence Pharma
Honasa acquires 58% stake in Fluence Pharma to enter the nutraceuticals segment. This marks a strategic expansion beyond its core beauty and personal care business. The deal underscores growing consolidation in India’s wellness sector. Fluence Pharma’s portfolio includes science-backed dietary supplements and functional foods.
📊 STOCKS: HONASA | 🏢 SECTOR: Corporate | #HIGHIMPACT #M&A
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.